Gabriele Obino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gabriele Obino has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Junior Lepedda
Department of Biomedical Sciences, University of Sassari, Viale San Pietro, 43b, 07100 Sassari, Italy
5 shared publications - Gabriele Nieddu
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
3 shared publications - Lorenzo Moroni
Maastricht University
3 shared publications - Marilena Formato
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
3 shared publications - Alberto Sensini
Department of Complex Tissue Regeneration MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Maastricht The Netherlands
2 shared publications - Cristina Ciampelli
Department of Biomedical Sciences, University of Sassari, Viale San Pietro, 43b, 07100 Sassari, Italy
2 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (15) , 7310-7330
Marine sulfated polysaccharides as biofunctional agents for enhancing hemocompatibility and endothelialization of tissue-engineered vascular grafts
Marine sulfated polysaccharides act as biologically instructive cues for next-generation vascular grafts by enhancing hemocompatibility, immunomodulation, endothelialization, and long-term vascular integration, ultimately promoting tissue regeneration.
- 30 May 2026
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (15) , 7310-7330
Open AccessMarine sulfated polysaccharides as biofunctional agents for enhancing hemocompatibility and endothelialization of tissue-engineered vascular grafts
Marine sulfated polysaccharides act as biologically instructive cues for next-generation vascular grafts by enhancing hemocompatibility, immunomodulation, endothelialization, and long-term vascular integration, ultimately promoting tissue regeneration.
- Open Access
- 2 May 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (23) , e04938
Copolymers of Poly(Butylene Trans‐1,4‐Cyclohexanedicarboxylate)/Pripol as New Biomaterial Platform for Small Diameter Vascular Graft
Autologous grafts remain the clinical gold standard for vascular reconstruction; however, their use is limited by donor site morbidity, poor availability, and long‐term failure. Synthetic alternatives, while effective in large‐caliber vessels, fail in small‐diameter applications (<6 mm) due to thrombosis, intimal hyperplasia, and biomechanical mismatch. In this context, tissue‐engineered vascular grafts (TEVGs) emerge as a solution, requiring biomaterials that closely replicate the structural, mechanical, and hemocompatible properties of native vessels. Aliphatic polyesters such as polylactic acid, polyglycolic acid, and poly(ε‐caprolactone) are extensively studied but show poor endothelialization and mechanical deficiency. In contrast, poly(butylene trans‐1,4‐cyclohexanedicarboxylate) (PBCE) attracts interest for its biocompatibility, thermal stability, and processability. Its copolymerization with Pripol 1009, a commercial fatty diacid, enables modulation of mechanical properties and degradation rate, two of the key parameters for vascular engineering. In this work, electrospun scaffolds based on these copolymers are fabricated in flat and tubular formats and characterized in terms of morphology, mechanical behavior, hemocompatibility, and endothelialization potential. Certain formulations display mechanical properties comparable to native vessels, support endothelialization and smooth muscle cell adhesion, and do not trigger coagulation pathways in in vitro assays. These results identify PBCE/Pripol copolymers as promising candidates for next‐generation TEVGs, bridging the gap between synthetic reliability and biological performance in small‐diameter vascular applications.
- 2 May 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (23) , e04938
Open AccessCopolymers of Poly(Butylene Trans‐1,4‐Cyclohexanedicarboxylate)/Pripol as New Biomaterial Platform for Small Diameter Vascular Graft
Autologous grafts remain the clinical gold standard for vascular reconstruction; however, their use is limited by donor site morbidity, poor availability, and long‐term failure. Synthetic alternatives, while effective in large‐caliber vessels, fail in small‐diameter applications (<6 mm) due to thrombosis, intimal hyperplasia, and biomechanical mismatch. In this context, tissue‐engineered vascular grafts (TEVGs) emerge as a solution, requiring biomaterials that closely replicate the structural, mechanical, and hemocompatible properties of native vessels. Aliphatic polyesters such as polylactic acid, polyglycolic acid, and poly(ε‐caprolactone) are extensively studied but show poor endothelialization and mechanical deficiency. In contrast, poly(butylene trans‐1,4‐cyclohexanedicarboxylate) (PBCE) attracts interest for its biocompatibility, thermal stability, and processability. Its copolymerization with Pripol 1009, a commercial fatty diacid, enables modulation of mechanical properties and degradation rate, two of the key parameters for vascular engineering. In this work, electrospun scaffolds based on these copolymers are fabricated in flat and tubular formats and characterized in terms of morphology, mechanical behavior, hemocompatibility, and endothelialization potential. Certain formulations display mechanical properties comparable to native vessels, support endothelialization and smooth muscle cell adhesion, and do not trigger coagulation pathways in in vitro assays. These results identify PBCE/Pripol copolymers as promising candidates for next‐generation TEVGs, bridging the gap between synthetic reliability and biological performance in small‐diameter vascular applications.
- Open Access
- 2 February 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (16) , e05314
Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small‐Caliber Vascular Grafts: A Multi‐Layered Strategy Combining Electrospinning and 4‐Axis Printing
The development of small‐caliber tissue‐engineered vascular grafts (sTEVGs) presents several challenges, including achieving balanced endothelialization, facilitating smooth muscle cell infiltration, preventing leakage, and ensuring anti‐thrombogenic properties, while maintaining mechanical strength sufficient to withstand physiological pressures, surgical handling, and suturing. Here, we present a multi‐layered polycaprolactone (PCL)‐based sTEVG using a combination of electrospinning and 4‐axis printing, providing precise control over scaffold porosity, fiber alignment, and tunable mechanical properties. To improve biocompatibility and hemocompatibility, the PCL nanofibers were functionalized with sulfated polysaccharides purified from the marine invertebrate Holothuria tubulosa , which significantly enhanced endothelialization and provided strong anti‐thrombogenic properties. The inner layer of tightly aligned electrospun nanofibers supported rapid formation of a mature endothelium, while preventing graft leakage even at supraphysiological pressure (>1100 mmHg). The middle layers, combining circumferential electrospun nanofibers and 4‐axis printed microfibers, increased scaffold porosity, and promoted adhesion, orientation and infiltration of human coronary artery smooth muscle cells (HCASMCs), facilitating functional tunica media formation. The outer layer of randomly oriented electrospun nanofibers contributed significantly to the mechanical properties of the graft, namely elasticity, toughness, burst pressure, and resistance to physiological vessel pressures, thus mimicking the tunica adventitia. The customizable four‐layered graft integrates structural and biological cues to address key limitations of sTEVGs, representing a valuableoff‐the‐shelf alternative to autologous grafts.
- 2 February 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (16) , e05314
Open AccessTunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small‐Caliber Vascular Grafts: A Multi‐Layered Strategy Combining Electrospinning and 4‐Axis Printing
The development of small‐caliber tissue‐engineered vascular grafts (sTEVGs) presents several challenges, including achieving balanced endothelialization, facilitating smooth muscle cell infiltration, preventing leakage, and ensuring anti‐thrombogenic properties, while maintaining mechanical strength sufficient to withstand physiological pressures, surgical handling, and suturing. Here, we present a multi‐layered polycaprolactone (PCL)‐based sTEVG using a combination of electrospinning and 4‐axis printing, providing precise control over scaffold porosity, fiber alignment, and tunable mechanical properties. To improve biocompatibility and hemocompatibility, the PCL nanofibers were functionalized with sulfated polysaccharides purified from the marine invertebrate Holothuria tubulosa , which significantly enhanced endothelialization and provided strong anti‐thrombogenic properties. The inner layer of tightly aligned electrospun nanofibers supported rapid formation of a mature endothelium, while preventing graft leakage even at supraphysiological pressure (>1100 mmHg). The middle layers, combining circumferential electrospun nanofibers and 4‐axis printed microfibers, increased scaffold porosity, and promoted adhesion, orientation and infiltration of human coronary artery smooth muscle cells (HCASMCs), facilitating functional tunica media formation. The outer layer of randomly oriented electrospun nanofibers contributed significantly to the mechanical properties of the graft, namely elasticity, toughness, burst pressure, and resistance to physiological vessel pressures, thus mimicking the tunica adventitia. The customizable four‐layered graft integrates structural and biological cues to address key limitations of sTEVGs, representing a valuableoff‐the‐shelf alternative to autologous grafts.
- Open Access
- 21 March 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (3) , 139
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus
Thromboembolic conditions are the most common cause of death in developed countries. Anticoagulant therapy is the treatment of choice, and heparinoids and warfarin are the most adopted drugs. Sulphated polysaccharides extracted from marine organisms have been demonstrated to be effective alternatives, blocking thrombus formation by inhibiting some factors involved in the coagulation cascade. In this study, four acidic glycan fractions from the marine sponge Sarcotragus spinosulus were purified by anion-exchange chromatography, and their anticoagulant properties were investigated through APTT and PT assays and compared with both standard glycosaminoglycans and holothurian sulphated polysaccharides. Moreover, their topographic localization was assessed through histological analysis, and their cytocompatibility was tested on a human fibroblast cell line. A positive correlation between the amount of acid glycans and the inhibitory effect towards both the intrinsic and extrinsic coagulation pathways was observed. The most effective anticoagulant activity was shown by a highly charged fraction, which accounted for almost half (about 40%) of the total hexuronate-containing polysaccharides. Its preliminary structural characterization, performed through infrared spectroscopy and nuclear magnetic resonance, suggested that it may consist of a fucosylated chondroitin sulphate, whose unique structure may be responsible for the anticoagulant activity reported herein for the first time.
- 21 March 2024
- Published by MDPI AG in Marine Drugs
- Vol. 22 (3) , 139
Open AccessPurification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus
Thromboembolic conditions are the most common cause of death in developed countries. Anticoagulant therapy is the treatment of choice, and heparinoids and warfarin are the most adopted drugs. Sulphated polysaccharides extracted from marine organisms have been demonstrated to be effective alternatives, blocking thrombus formation by inhibiting some factors involved in the coagulation cascade. In this study, four acidic glycan fractions from the marine sponge Sarcotragus spinosulus were purified by anion-exchange chromatography, and their anticoagulant properties were investigated through APTT and PT assays and compared with both standard glycosaminoglycans and holothurian sulphated polysaccharides. Moreover, their topographic localization was assessed through histological analysis, and their cytocompatibility was tested on a human fibroblast cell line. A positive correlation between the amount of acid glycans and the inhibitory effect towards both the intrinsic and extrinsic coagulation pathways was observed. The most effective anticoagulant activity was shown by a highly charged fraction, which accounted for almost half (about 40%) of the total hexuronate-containing polysaccharides. Its preliminary structural characterization, performed through infrared spectroscopy and nuclear magnetic resonance, suggested that it may consist of a fucosylated chondroitin sulphate, whose unique structure may be responsible for the anticoagulant activity reported herein for the first time.
- Open Access
- 18 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12449
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report
Carotid atherosclerosis represents a relevant healthcare problem, since unstable plaques are responsible for approximately 15% of neurologic events, namely transient ischemic attack and stroke. Although statins treatment has proven effective in reducing LDL-cholesterol and the onset of acute clinical events, a residual risk may persist suggesting the need for the detection of reliable molecular markers useful for the identification of patients at higher risk regardless of optimal medical therapy. In this regard, several lines of evidence show a relationship among specific biologically active plasma lipids, atherosclerosis, and acute clinical events. We performed a Selected Reaction Monitoring-based High Performance Liquid Chromatography-tandem Mass Spectrometry (SRM-based HPLC-MS/MS) analysis on plasma HDL, LDL, and VLDL fractions purified, by isopycnic salt gradient ultracentrifugation, from twenty-eight patients undergoing carotid endarterectomy, having either a “hard” or a “soft” plaque, with the aim of characterizing the specific lipidomic patterns associated with features of carotid plaque instability. One hundred and thirty lipid species encompassing different lipid (sub)classes were monitored. Supervised multivariate analysis showed that lipids belonging to phosphatidylethanolamine (PE), sphingomyelin (SM), and diacylglycerol (DG) classes mostly contribute to discrimination within each lipoprotein fraction according to the plaque typology. Differential analysis evidenced a significant dysregulation of LDL PE (38:6), SM (32:1), and SM (32:2) between the two groups of patients (adj. p-value threshold = 0.05 and log2FC ≥ |0.58|). Using this approach, some LDL-associated markers of plaque vulnerability have been identified, in line with the current knowledge of the key roles of these phospholipids in lipoprotein metabolism and cardiovascular disease. This proof-of-concept study reports promising results, showing that lipoprotein lipidomics may present a valuable approach for identifying new biomarkers of potential clinical relevance.
- 18 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12449
Open AccessMolecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report
Carotid atherosclerosis represents a relevant healthcare problem, since unstable plaques are responsible for approximately 15% of neurologic events, namely transient ischemic attack and stroke. Although statins treatment has proven effective in reducing LDL-cholesterol and the onset of acute clinical events, a residual risk may persist suggesting the need for the detection of reliable molecular markers useful for the identification of patients at higher risk regardless of optimal medical therapy. In this regard, several lines of evidence show a relationship among specific biologically active plasma lipids, atherosclerosis, and acute clinical events. We performed a Selected Reaction Monitoring-based High Performance Liquid Chromatography-tandem Mass Spectrometry (SRM-based HPLC-MS/MS) analysis on plasma HDL, LDL, and VLDL fractions purified, by isopycnic salt gradient ultracentrifugation, from twenty-eight patients undergoing carotid endarterectomy, having either a “hard” or a “soft” plaque, with the aim of characterizing the specific lipidomic patterns associated with features of carotid plaque instability. One hundred and thirty lipid species encompassing different lipid (sub)classes were monitored. Supervised multivariate analysis showed that lipids belonging to phosphatidylethanolamine (PE), sphingomyelin (SM), and diacylglycerol (DG) classes mostly contribute to discrimination within each lipoprotein fraction according to the plaque typology. Differential analysis evidenced a significant dysregulation of LDL PE (38:6), SM (32:1), and SM (32:2) between the two groups of patients (adj. p-value threshold = 0.05 and log2FC ≥ |0.58|). Using this approach, some LDL-associated markers of plaque vulnerability have been identified, in line with the current knowledge of the key roles of these phospholipids in lipoprotein metabolism and cardiovascular disease. This proof-of-concept study reports promising results, showing that lipoprotein lipidomics may present a valuable approach for identifying new biomarkers of potential clinical relevance.